From wiki-pain
Revision as of 15:28, 20 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.03
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 1.16
Pain Relevance 0.17

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Sle1 (Mus musculus)
Pain Link Frequency Relevance Heat
cytokine 13 78.08 Quite High
Inflammation 4 59.60 Quite High
antagonist 1 55.76 Quite High
Infliximab 1 39.68 Quite Low
Arthritis 4 21.92 Low Low
abatacept 5 5.00 Very Low Very Low Very Low
rheumatoid arthritis 5 5.00 Very Low Very Low Very Low
chemokine 2 5.00 Very Low Very Low Very Low
corticosteroid 1 5.00 Very Low Very Low Very Low
Inflammatory response 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Systemic Lupus Erythematosus 52 100.00 Very High Very High Very High
Renal Disease 22 90.80 High High
Proteinuria 3 84.64 Quite High
Infection 5 72.40 Quite High
Autoimmune Disease 5 65.68 Quite High
INFLAMMATION 4 59.60 Quite High
Diabetes Mellitus 1 55.04 Quite High
Hirsutism 1 52.28 Quite High
Gingival Hypertrophy 1 51.56 Quite High
Nephrotoxicity 1 38.52 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Used in many transplant patients, there is a limited use in SLE patients despite the fact the mTOR seems to be an imported mediator in SLE.37,38 A prospective Phase II trial of sirolimus for the treatment of SLE is recruiting patients.
Positive_regulation (imported) of Positive_regulation (mediator) of SLE associated with systemic lupus erythematosus
1) Confidence 0.03 Published 2010 Journal Biologics : Targets & Therapy Section Body Doc Link PMC2943198 Disease Relevance 1.16 Pain Relevance 0.17

General Comments

This test has worked.

Personal tools